Risk and mortality of aspiration pneumonia in Parkinson’s disease: a nationwide database study

Abstract This retrospective cohort study investigated the risk and mortality rate due to aspiration pneumonia in patients with Parkinson’s disease (PD) using a nationwide database. We identified 10,159 newly diagnosed PD patients between 2004 and 2006, and four age- and sex-matched controls for each...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jun Hee Won, Seong Jun Byun, Byung-Mo Oh, Sang Jun Park, Han Gil Seo
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3f2058d66373455fac0d85ad172e5c15
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3f2058d66373455fac0d85ad172e5c15
record_format dspace
spelling oai:doaj.org-article:3f2058d66373455fac0d85ad172e5c152021-12-02T16:36:04ZRisk and mortality of aspiration pneumonia in Parkinson’s disease: a nationwide database study10.1038/s41598-021-86011-w2045-2322https://doaj.org/article/3f2058d66373455fac0d85ad172e5c152021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-86011-whttps://doaj.org/toc/2045-2322Abstract This retrospective cohort study investigated the risk and mortality rate due to aspiration pneumonia in patients with Parkinson’s disease (PD) using a nationwide database. We identified 10,159 newly diagnosed PD patients between 2004 and 2006, and four age- and sex-matched controls for each PD patient from the National Health Insurance Service database in Korea. We analyzed the relative risk of aspiration pneumonia and mortality after the first occurrence of aspiration pneumonia until 2017. Throughout the study period, PD patients showed a higher incidence of aspiration pneumonia than their matched controls (3.01 vs. 0.59 events per 1,000 person-years), and they were at an increased risk of aspiration pneumonia (hazard ratio = 4.21; 95% confidence interval, 3.87–4.58). After the first occurrence of aspiration pneumonia, the mortality rate of PD patients was 23.9% after one month, 65.2% after 1 year, and 91.8% after 5 years, while that of controls was 30.9%, 67.4%, and 88.9%, respectively. Patients with PD are at an increased risk of aspiration pneumonia, and approximately two-thirds of the patients die within a year after experiencing aspiration pneumonia. Further studies are warranted to prevent aspiration pneumonia and implement proper treatments to prevent death after aspiration pneumonia in patients with PD.Jun Hee WonSeong Jun ByunByung-Mo OhSang Jun ParkHan Gil SeoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jun Hee Won
Seong Jun Byun
Byung-Mo Oh
Sang Jun Park
Han Gil Seo
Risk and mortality of aspiration pneumonia in Parkinson’s disease: a nationwide database study
description Abstract This retrospective cohort study investigated the risk and mortality rate due to aspiration pneumonia in patients with Parkinson’s disease (PD) using a nationwide database. We identified 10,159 newly diagnosed PD patients between 2004 and 2006, and four age- and sex-matched controls for each PD patient from the National Health Insurance Service database in Korea. We analyzed the relative risk of aspiration pneumonia and mortality after the first occurrence of aspiration pneumonia until 2017. Throughout the study period, PD patients showed a higher incidence of aspiration pneumonia than their matched controls (3.01 vs. 0.59 events per 1,000 person-years), and they were at an increased risk of aspiration pneumonia (hazard ratio = 4.21; 95% confidence interval, 3.87–4.58). After the first occurrence of aspiration pneumonia, the mortality rate of PD patients was 23.9% after one month, 65.2% after 1 year, and 91.8% after 5 years, while that of controls was 30.9%, 67.4%, and 88.9%, respectively. Patients with PD are at an increased risk of aspiration pneumonia, and approximately two-thirds of the patients die within a year after experiencing aspiration pneumonia. Further studies are warranted to prevent aspiration pneumonia and implement proper treatments to prevent death after aspiration pneumonia in patients with PD.
format article
author Jun Hee Won
Seong Jun Byun
Byung-Mo Oh
Sang Jun Park
Han Gil Seo
author_facet Jun Hee Won
Seong Jun Byun
Byung-Mo Oh
Sang Jun Park
Han Gil Seo
author_sort Jun Hee Won
title Risk and mortality of aspiration pneumonia in Parkinson’s disease: a nationwide database study
title_short Risk and mortality of aspiration pneumonia in Parkinson’s disease: a nationwide database study
title_full Risk and mortality of aspiration pneumonia in Parkinson’s disease: a nationwide database study
title_fullStr Risk and mortality of aspiration pneumonia in Parkinson’s disease: a nationwide database study
title_full_unstemmed Risk and mortality of aspiration pneumonia in Parkinson’s disease: a nationwide database study
title_sort risk and mortality of aspiration pneumonia in parkinson’s disease: a nationwide database study
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3f2058d66373455fac0d85ad172e5c15
work_keys_str_mv AT junheewon riskandmortalityofaspirationpneumoniainparkinsonsdiseaseanationwidedatabasestudy
AT seongjunbyun riskandmortalityofaspirationpneumoniainparkinsonsdiseaseanationwidedatabasestudy
AT byungmooh riskandmortalityofaspirationpneumoniainparkinsonsdiseaseanationwidedatabasestudy
AT sangjunpark riskandmortalityofaspirationpneumoniainparkinsonsdiseaseanationwidedatabasestudy
AT hangilseo riskandmortalityofaspirationpneumoniainparkinsonsdiseaseanationwidedatabasestudy
_version_ 1718383626500964352